How should I interpret the scores on the Adult ADHD Self‑Report Scale version 1.1 (ASRS‑v1.1)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Interpret ASRS-v1.1 Scores

The ASRS-v1.1 is a screening tool only—a positive result requires comprehensive clinical evaluation including collateral information from family or close contacts, as adults with ADHD typically underestimate their symptom severity and functional impairment. 1

Scoring Methods and Cut-offs

Standard Dichotomous Scoring (Part A - 6 Questions)

  • The original ASRS-v1.1 screener uses 6 questions (Part A) with specific thresholds for each item 2
  • Mark responses of "sometimes," "often," or "very often" as positive for questions 1-3
  • Mark responses of "often" or "very often" as positive for questions 4-6
  • A positive screen requires ≥4 out of 6 items meeting threshold 2
  • This method yields sensitivity of 79-100% and specificity of 70-91% across populations 3, 2

Alternative Quantitative Scoring (Full 18-Item Scale)

  • Score each item from 0-4 points (never=0, rarely=1, sometimes=2, often=3, very often=4) 4
  • Total possible score ranges from 0-72 points
  • A cut-off of ≥12 points on the 6-item screener demonstrates optimal diagnostic accuracy (sensitivity 96.7%, specificity 91.1%) 4
  • Mean normative score in US general population is 2.0 (SD=3.2), varying by age and sex 5

Clinical Context and Limitations

What the ASRS Cannot Do

  • The ASRS does not establish an ADHD diagnosis—it only identifies individuals requiring further evaluation 1
  • Self-report alone is insufficient because adults with ADHD characteristically lack insight into symptom severity 6, 1
  • The scale cannot differentiate ADHD from conditions with overlapping symptoms (bipolar disorder, depression, borderline personality disorder, anxiety disorders, learning disabilities, narcolepsy, substance use disorders) 6, 1

Required Follow-up for Positive Screens

  • Obtain detailed psychiatric and medical history documenting core ADHD symptoms beginning in childhood (before age 7 per DSM-IV criteria referenced in guidelines) 6
  • Collect collateral information from spouse, parent, or significant other to verify symptom presence and severity 6, 1
  • Document moderate-to-severe functional impairment in at least two settings (occupational/academic, social, family) 6
  • Perform medical history, physical examination, and screening labs to exclude medical mimics 6
  • Assess for comorbid conditions: depression (58% prevalence in ADHD), anxiety (53%), sleep difficulties (37%), and substance use disorders 5
  • Consider urine drug screening given high comorbidity with substance abuse 6

Interpretation Pitfalls

Common Errors to Avoid

  • Do not diagnose ADHD based solely on ASRS score—this violates the screening-only purpose of the instrument 1
  • Do not skip collateral informant interviews, as self-report systematically underestimates impairment 6, 1
  • Current symptomatology predicts functional impairment better than formal diagnosis status—symptomatic but undiagnosed individuals show comparable or worse quality of life outcomes 7
  • The positive predictive value ranges from 18-92% depending on population prevalence, meaning many positive screens will not have ADHD upon full evaluation 3, 2, 4
  • The negative predictive value is excellent (96-100%), making the ASRS most useful for ruling out ADHD when negative 3, 2, 4

Administration Considerations

  • The screener takes approximately 54 seconds to complete, making it practical for busy clinical settings 2
  • Psychometric properties remain valid across diverse populations including those with comorbid psychiatric conditions 8, 3
  • No site-specific differences in performance have been identified 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.